Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary TogglePreclinical Data Presented at Scientific Symposium Demonstrates That mRNA is Efficiently Delivered Using Tekmira's LNP Oct 24, 2013 Preclinical Data Presented at Scientific Symposium Demonstrates That mRNA is Efficiently Delivered Using Tekmira's LNP 22.8 KB ... Read more Summary ToggleTekmira Announces Completion of US$30 Million Public Offering of Common Stock Oct 22, 2013 Tekmira Announces Completion of US$30 Million Public Offering of Common Stock 19.8 KB ... Read more Summary ToggleTekmira Prices Public Offering of Common Stock Oct 17, 2013 Tekmira Prices Public Offering of Common Stock 20.5 KB ... Read more Summary ToggleTekmira Announces Proposed Public Offering of Common Stock Oct 16, 2013 Tekmira Announces Proposed Public Offering of Common Stock 20.6 KB ... Read more Summary ToggleTekmira Provides Corporate Update on RNAi Therapeutics Pipeline Oct 08, 2013 ... Read more Summary ToggleTekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer Oct 07, 2013 Tekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer 18.7 KB ... Read more Summary ToggleTekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference Oct 04, 2013 Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference 25 KB ... Read more Summary ToggleTekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline Oct 03, 2013 Tekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline 13.5 KB ... Read more Summary ToggleTekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus Sep 25, 2013 Tekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus 25.6 KB Studies Achieved 100% Protection Against Most Deadly Strain of Marburg Virus When Dosed 24 Hours After Lethal Exposure Levels in Non-Human Primates Using RNAi Therapeutic Developed by Tekmira and Its Collaborators ... Read more Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Sep 03, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19.2 KB Spectrum Pharmaceuticals Launches Marqibo and Ships First Commercial Orders ... Read more Pagination First page First Previous page Previous … Page 33 Current page 34 Page 35 Page 36 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary TogglePreclinical Data Presented at Scientific Symposium Demonstrates That mRNA is Efficiently Delivered Using Tekmira's LNP Oct 24, 2013 Preclinical Data Presented at Scientific Symposium Demonstrates That mRNA is Efficiently Delivered Using Tekmira's LNP 22.8 KB ... Read more Summary ToggleTekmira Announces Completion of US$30 Million Public Offering of Common Stock Oct 22, 2013 Tekmira Announces Completion of US$30 Million Public Offering of Common Stock 19.8 KB ... Read more Summary ToggleTekmira Prices Public Offering of Common Stock Oct 17, 2013 Tekmira Prices Public Offering of Common Stock 20.5 KB ... Read more Summary ToggleTekmira Announces Proposed Public Offering of Common Stock Oct 16, 2013 Tekmira Announces Proposed Public Offering of Common Stock 20.6 KB ... Read more Summary ToggleTekmira Provides Corporate Update on RNAi Therapeutics Pipeline Oct 08, 2013 ... Read more Summary ToggleTekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer Oct 07, 2013 Tekmira Appoints Bruce Cousins as Executive Vice President and Chief Financial Officer 18.7 KB ... Read more Summary ToggleTekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference Oct 04, 2013 Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference 25 KB ... Read more Summary ToggleTekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline Oct 03, 2013 Tekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline 13.5 KB ... Read more Summary ToggleTekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus Sep 25, 2013 Tekmira Presents New Anti-Viral Efficacy Data Against the Marburg Hemorrhagic Fever Virus 25.6 KB Studies Achieved 100% Protection Against Most Deadly Strain of Marburg Virus When Dosed 24 Hours After Lethal Exposure Levels in Non-Human Primates Using RNAi Therapeutic Developed by Tekmira and Its Collaborators ... Read more Summary ToggleTekmira Provides Update on Licensed Product Candidate, Marqibo(R) Sep 03, 2013 Tekmira Provides Update on Licensed Product Candidate, Marqibo(R) 19.2 KB Spectrum Pharmaceuticals Launches Marqibo and Ships First Commercial Orders ... Read more Pagination First page First Previous page Previous … Page 33 Current page 34 Page 35 Page 36 … Next page Next Last page Last
Preclinical Data Presented at Scientific Symposium Demonstrates That mRNA is Efficiently Delivered Using Tekmira's LNP 22.8 KB
Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference 25 KB
Tekmira to Host Research and Development Webinar Providing Corporate Update on Product Pipeline 13.5 KB
